• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

What is the call about tomorrow? There are 3





























BI as well, I hear....hmmmmm...someone has to know something!

So syneos has a call, pc3 has a call, pc1 and 2 have a call AND BI has a call?

Sounds like a major shakeup to me. I thought it might just be about the new farxiga indication, or syneos getting bought out but there's no reason for 1 2 to have a call for that. Things Getting spicy. Should be interesting.
 












PC3 going to Mounjaro for weight loss? Specialty? PC2 already calls on PCP for diabetes. Contract to keep Jardiance? You think Lilly will absorb Syneos contract reps? Still weird all the calls....seems fishy